Rapid Micro Biosystems Q2 FY26 net loss widens to $12.9 million; revenue rises 11% to $8.1 million

Reuters2026/08/07 11:02

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Rapid Micro Biosystems Q2 2026 revenue rose 11% to USD 8.1 million, driven by product revenue of USD 5.3 million.
Net loss widened to USD 12.9 million; loss per share was USD 0.27.
Gross margin climbed to 15%, up 11 percentage points from a year earlier.
Placed four Growth Direct systems, completed nine validations; reached the 200th system placed globally.
Reaffirmed 2026 revenue guidance of USD 37 million-USD 41 million; expects 30-38 system placements, gross margin about 20%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rapid Micro Biosystems Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608070700PRIMZONEFULLFEED9805918) on August 07, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Rapid Micro Biosystems Q2 FY26 net loss widens to $12.9 million; revenue rises 11% to $8.1 million

You may also like

Crypto prices